Eledon Pharmaceuticals, Inc. ("Eledon”) (NASDAQ: ELDN) today announced updated results from an investigator-initiated trial con ...

Highlighting the Companies Powering Faster Charging, Smarter Devices, and the Future of Universal Connectivity.

NRx has received confirmatory FDA minutes from in-person Type C meeting attended by leadership of FDA Division of Psychiatry, FDA Office of Neuroscience, and FDA Center for Drug Evaluation and ...

When Anastasios Tzanidakis was sifting through some older telescope observations, he stumbled across something that should ...

Memories.ai is building a large visual memory model that can index and retrieve video-recorded memories for physical AI.

How central is China to your global sustainability roadmap and next-generation technology deployment? Dreyer: China's progress in reducing energy intensity and expanding energy storage aligns with ...

Metapack reports that high-volume shippers often miss key delivery blind spots, impacting efficiency and customer ...

From predicting domestic violence risk to expanding world-class care across Ohio, here's what's new in medicine that could ...

On Monday morning, Attorney General Letitia James joined together with state lawmakers and union representatives, calling for ...

A Bank of America Institute analysis of 2,000 years of GDP data reframes American exceptionalism — and points toward what ...

Eledon Pharmaceuticals, Inc. is rated a Strong Buy following positive phase 2 BESTOW results for tegoprubart. Read more on ELDN stock here.

Here are three concrete cybersecurity strategies executives can implement to preserve deal value and sustain brand equity post-closing.